Bitcoin Whale Just Transferred $97M BTC From Coinbase To Binance
What happened: An anonymous Bitcoin (CRYPTO: BTC) whale just transferred $97,458,061 worth of Bitcoin off Coinbase, and the investor then sent these funds to Binance.
This Wallet Just Transferred $279M Worth Of BTC Onto Gemini
What happened: An anonymous cryptocurrency wallet holding $279,254,942 of Bitcoin (CRYPTO: BTC) just transferred their funds onto Gemini. The bitcoin wallet address tied to this transfer has been identified as:
3Kzh9qAqVWQhEsfQz7zEQL1EuSx5tyNLNS
Analyzing Hess’s Short Interest
Hess's (NYSE:HES) short percent of float has risen 29.88% since its last report. The company recently reported that it has 8.70 million shares sold short, which is 3.26% of all regular shares that are available for trading.
Piper Sandler Maintains Neutral Rating for MarketAxess Holdings: Here’s What You Need To Know
Piper Sandler has decided to maintain its Neutral rating of MarketAxess Holdings (NASDAQ:MKTX) and lower its price target from $300.00 to $285.00.
Shares of MarketAxess Holdings are trading down 0.69% over the last 24 hours, at $254.25 per share.
Expert Ratings for Zions Bancorp
Analysts have provided the following ratings for Zions Bancorp (NASDAQ:ZION) within the last quarter:
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $6,500 Today
Nucor (NYSE:NUE) has outperformed the market over the past 20 years by 2.74% on an annualized basis producing an average annual return of 9.83%. Currently, Nucor has a market capitalization of $27.86 billion.
Wells Fargo Maintains Equal-Weight Rating for JPMorgan Chase: Here’s What You Need To Know
Wells Fargo has decided to maintain its Equal-Weight rating of JPMorgan Chase (NYSE:JPM) and lower its price target from $150.00 to $120.00.
Shares of JPMorgan Chase are trading down 0.2% over the last 24 hours, at $112.38 per share.
Looking Into HCA Healthcare’s Recent Short Interest
HCA Healthcare's (NYSE:HCA) short percent of float has fallen 20.59% since its last report. The company recently reported that it has 5.06 million shares sold short, which is 1.89% of all regular shares that are available for trading.
HC Wainwright & Co. Maintains Buy Rating for Celldex Therapeutics: Here’s What You Need To Know
HC Wainwright & Co. has decided to maintain its Buy rating of Celldex Therapeutics (NASDAQ:CLDX) and raise its price target from $60.00 to $73.00.
Shares of Celldex Therapeutics are trading down 14.91% over the last 24 hours, at $22.94 per share.
Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here’s What You Need To Know
Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00.
Shares of Haemonetics are trading up 1.46% over the last 24 hours, at $66.13 per share.
A move to $70.00 would account for a 5.85% increase from the current share price.